Continuous Glucose Monitoring (CGM) Market Size, Share & Trends Analysis By Product (CGM Sensors, CGM Transmitters, CGM Receivers, CGM Smart Devices), By Type (Real-Time CGM, Flash Glucose Monitoring), By Connectivity (Bluetooth CGM, NFC CGM), By End-Use (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Non-Diabetic Use), By Distribution (Hospital, Retail Pharmacy, Online), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

Market Overview

According to Novatrends Market Intelligence, the Global Continuous Glucose Monitoring Market was valued at USD 9.8 billion in 2025 and is anticipated to propel at a growth rate of 16.2% from 2026-2036.

The continuous glucose monitoring market encompasses CGM device market products — CGM sensor technology, transmitters, receivers, and CGM smart devices — that provide wearable glucose sensor real-time glucose monitoring of interstitial fluid glucose levels every 1–5 minutes for diabetes self-management and clinical monitoring. Real-time glucose monitoring CGM systems provide continuous readings with alerts for hypoglycemia and hyperglycemia, while flash glucose monitoring (FGM) requires user scanning to retrieve the latest reading from the wearable glucose sensor. CGM sensor technology has advanced to 10–15 day wear durations with factory-calibrated CGM accuracy and calibration, eliminating fingerstick calibration requirements. CGM for type 1 diabetes and CGM for type 2 diabetes represent the primary end-use segments; insulin pump integration CGM (closed-loop "artificial pancreas") systems like the Omnipod 5 and Tandem Control-IQ combine real-time glucose monitoring with automated insulin delivery. Implantable CGM sensor (Senseonics Eversense) enables 6-month implantable continuous glucose monitoring for patients preferring non-disposable wearable glucose sensor platforms. CGM connectivity via Bluetooth CGM and NFC CGM transmits CGM data management to smartphones for AI-powered CGM analytics and remote CGM monitoring by caregivers and clinicians. CGM for pediatric diabetes is a growing segment as CGM market trends show expanding use in children and adolescents. CGM market size is expected to grow significantly as CGM market forecast for type 2 diabetes penetration expands beyond premium segments with price declines.

Market Dynamics

The market is driven by expanding diabetes prevalence (540M+ people), CGM reimbursement expansion for type 2 diabetes in the U.S. and EU, and CGM market growth from adoption by non-diabetic users for metabolic health monitoring. Flash glucose monitoring and real-time glucose monitoring CGM market trends show Abbott FreeStyle Libre and Dexcom G7 competition driving CGM device market price competition and CGM accuracy and calibration improvement. Insulin pump integration CGM hybrid closed-loop adoption is expanding CGM for type 1 diabetes average selling prices and device attachment. AI-powered CGM analytics apps for pattern analysis, predictive alerts, and CGM data management are differentiating connected CGM connectivity platforms. Remote CGM monitoring by endocrinologists and diabetes care teams using CGM data management cloud platforms is improving time-in-range outcomes. CGM for pediatric diabetes growth is supported by expanding pediatric CGM reimbursement. Implantable CGM sensor development is advancing with Senseonics and competitors. In January 2024, Abbott Diabetes Care expanded flash glucose monitoring and CGM market size with FreeStyle Libre 3 Plus, while Dexcom launched CGM for type 2 diabetes CGM device market expansion with Stelo OTC CGM. CGM market forecast through 2036 is supported by new user segments and technology improvements in wearable glucose sensor miniaturization.

Segment Analysis

By Product: CGM Sensors holds the largest share of the Continuous Glucose Monitoring (CGM) market, supported by strong adoption and well-established supply chains across key end-use industries. CGM Transmitters is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Type: Real-Time CGM holds the largest share of the Continuous Glucose Monitoring (CGM) market, supported by strong adoption and well-established supply chains across key end-use industries. Flash Glucose Monitoring is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By End-Use: Type 1 Diabetes holds the largest share of the Continuous Glucose Monitoring (CGM) market, supported by strong adoption and well-established supply chains across key end-use industries. Type 2 Diabetes is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Distribution: Hospital holds the largest share of the Continuous Glucose Monitoring (CGM) market, supported by strong adoption and well-established supply chains across key end-use industries. Retail Pharmacy is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

Recent Developments in Continuous Glucose Monitoring Market

• In January 2024, Abbott Diabetes Care expanded flash glucose monitoring and continuous glucose monitoring market with FreeStyle Libre 3 Plus wearable glucose sensor, advancing CGM accuracy and calibration, CGM connectivity Bluetooth CGM, and real-time glucose monitoring with 15-day wear duration for CGM for type 1 diabetes and CGM for type 2 diabetes management.
• In April 2024, Dexcom Inc. launched Stelo OTC continuous glucose monitoring CGM device market product for CGM for type 2 diabetes and non-diabetic health monitoring, advancing CGM market growth and CGM market size by expanding wearable glucose sensor access without prescription through retail pharmacy CGM connectivity distribution.
• In July 2024, Medtronic Diabetes (Guardian 4) advanced insulin pump integration CGM and real-time glucose monitoring with MiniMed 780G artificial pancreas CGM for type 1 diabetes, delivering improved CGM accuracy and calibration, AI-powered CGM analytics, and remote CGM monitoring for pediatric and adult CGM for type 1 diabetes closed-loop management.
• In September 2024, Senseonics (Eversense E3) advanced implantable CGM sensor and continuous glucose monitoring market with Eversense E3 365-day implantable wearable glucose sensor, targeting CGM for type 1 diabetes and CGM for type 2 diabetes patients preferring implantable CGM sensor over disposable CGM device market products.
• In December 2024, Roche Diabetes Care (Accu-Chek Smartguide) expanded flash glucose monitoring and CGM device market with Accu-Chek Smartguide CGM sensor technology, advancing CGM connectivity, AI-powered CGM analytics, and CGM data management for CGM for type 2 diabetes in European and Asia Pacific continuous glucose monitoring markets.
• In March 2025, Sibionics (China) advanced CGM market trends in Asia with affordable wearable glucose sensor and real-time glucose monitoring CGM sensor technology for CGM for type 2 diabetes in Chinese, Indian, and Southeast Asian markets, driving CGM market growth and CGM market forecast by expanding CGM market size in high-prevalence emerging markets.

Top Continuous Glucose Monitoring Market - Key Market Players

• Abbott Diabetes Care (FreeStyle Libre)
• Dexcom Inc.
• Medtronic Diabetes
• Senseonics Inc.
• Roche Diabetes Care
• Sibionics Ltd.
• Movano Health
• Know Labs Inc.
• Glucowise (MediWise)
• Cnoga Medical Ltd.
• GlucoLight Corporation
• Integrity Applications Inc.
• POCTech Co. Ltd.
• Nemaura Medical
• January AI

Global Continuous Glucose Monitoring (CGM) Market Report- Scope (Customizable)

Detailed Market Segmentation

• By Product (Revenue in USD Million)
  • CGM Sensors
  • CGM Transmitters
  • CGM Receivers
  • CGM Smart Devices
• By Type (Revenue in USD Million)
  • Real-Time CGM
  • Flash Glucose Monitoring
• By End-Use (Revenue in USD Million)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Non-Diabetic Use
• By Distribution (Revenue in USD Million)
  • Hospital
  • Retail Pharmacy
  • Online
• By Region (Revenue in USD Million)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Central & South America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt
    • South Africa